Organometallics
Article
55.96; H, 4.27; N, 5.93. Found: C, 56.03; H, 4.36; N, 5.73. MS (ESI):
m/z 391 [M − Br]+.
(391 mg, 9.78 mmol, 1.50 equiv), and 2c (3.08 g, 6.52 mmol, 1.00
1
equiv). A white solid was obtained (2.03 g, 4.34 mmol, 67%). H
1-Isobutyl-3-(3-bromopropyl)benzimidazolium Bromide
(3b). 1b (8.00 g, 46.0 mmol) was dissolved in 1,3-dibromopropane
(50 mL) and heated to 85 °C for 15 h. Then the volatiles were
distilled off under reduced pressure, and the solid residue was
extracted with dichloromethane (150 mL). The resulting suspension
was filtered, and the solvent of the filtrate was evaporated. The residue
was washed with acetone (50 mL) to yield a white solid (8.57 g, 22.8
mmol, 50%). 1H NMR (300 MHz, CDCl3): δ 11.25 (s, 1 H, NCHN),
NMR (300 MHz, CDCl3): δ 10.42 (s, 1 H, NCHN), 7.80 (d, 3JH−H
=
4
3
9 Hz, 1 H, Ar-H), 7.58 (dt, JH−H = 1 Hz, JH−H = 8 Hz, 1 H, Ar-H),
7.50−7.35 (m, 12 H, Ar-H), 7.27 (s, 1 H, NCHPh2), 4.99 (t, 3JH−H = 6
Hz, 2 H, NCH2), 3.10 (t, 3JH−H = 6 Hz, 2 H, SCH2), 3.09 (sept, 3JH−H
= 7 Hz, 1 H, SCH), 1.16 (d, 3JH−H = 7 Hz, 6 H, CH3). 13C{1H} NMR
(75 MHz, CDCl3): δ 144.0 (NCHN), 135.7, 132.5, 131.7, 130.3,
129.2, 127.9, 127.7, 115.4, 114.0 (Ar-C), 67.4 (NCHPh2), 47.9
(NCH2), 35.6 (SCH), 30.5 (SCH2), 24.0 (CH3). Mp: 214 °C. Anal.
Calcd for C25H27BrN2S: C, 64.23; H, 5.82; N, 5.99. Found: C, 64.25;
H, 5.58; N, 5.90. MS (ESI): m/z 387 [M − Br]+.
7.88−7.83 (m, 1 H, Ar-H), 7.74−7.63 (m 3 H, Ar-H), 4.90 (t, 3JH−H
=
7 Hz, 2 H, NCH2), 4.41 (d, 3JH−H = 7 Hz, 2 H, NCH2), 3.56 (t, 3JH−H
= 6 Hz, 2 H, CH2Br), 2.71 (tt, 3JH−H = 6 Hz, 3JH−H = 7 Hz, 2 H, CH2),
2.41 (sept, 3JH−H = 7 Hz, 1 H, CH), 1.01 (d, 3JH−H = 7 Hz, 6 H, CH3).
13C{1H} NMR (75 MHz, CDCl3): δ 143.7 (NCHN), 132.1, 132.0,
1-Benzyl-3-(3-(isopropylthio)propyl)benzimidazolium Bro-
mide (5a). 5a was prepared in analogy to 4a from 2-mercaptopropane
(3.05 mL, 33.0 mmol, 1.50 equiv), sodium hydroxide (1.32 g, 33.0
mmol, 1.50 equiv), and 3a (9.02 g, 22.0 mmol, 1.00 equiv). An off-
128.0, 127.9, 113.9, 113.8 (Ar-C), 55.2 (NCH2), 46.5 (NCH2), 32.8
(CH2), 30.4 (CH2), 29.6 (CH2Br), 20.6 (CH3). Mp: 192 °C. Anal.
Calcd for C14H20Br2N2·CH2Cl2: C, 43.07; H, 5.20; N, 7.05. Found: C,
42.76; H, 5.15; N, 7.45. MS (ESI): m/z 295 [M − Br]+.
1
white solid was obtained (5.24 g, 12.9 mmol, 58%). H NMR (300
MHz, CDCl3): δ 11.70 (s, 1 H, NCHN), 7.81−7.75 (m, 1 H, Ar-H),
7.63−7.47 (m, 5 H, Ar-H), 7.39−7.30 (m, 3 H, Ar-H), 5.87 (s, 2 H,
3
3
NCH2Ph), 4.77 (t, JH−H = 8 Hz, 2 H, NCH2), 2.90 (sept, JH−H = 7
Hz, 1 H, SCH), 2.67 (t, 3JH−H = 7 Hz, 2 H, SCH2), 2.40 (tt, 3JH−H = 7
1-Benzhydryl-3-(3-bromopropyl)benzimidazolium Bromide
(3c). 3c was prepared in analogy to 3b from 1c (1.80 g, 6.34 mmol)
and 1,3-dibromopropane (10 mL). A white solid was obtained (1.74 g,
3
3
Hz, JH−H = 8 Hz, 2 H, CH2), 1.21 (d, JH−H = 7 Hz, 6 H, CH3).
3.58 mmol, 57%). H NMR (300 MHz, CDCl3): δ 10.82 (s, 1 H,
13C{1H} NMR (75 MHz, CDCl3): δ 143.9 (NCHN), 133.3, 132.3,
1
3
NCHN), 7.86 (d, JH−H = 8 Hz, 1 H, Ar-H), 7.68−7.59 (m, 1 H, Ar-
131.8, 130.0, 129.9, 129.1, 127.9, 127.8, 114.4, 113.8 (Ar-C), 52.1
(NCH2Ph), 46.9 (NCH2), 36.0 (SCH), 29.8 (SCH2), 27.9 (CH2),
24.0 (CH3). Mp: 90 °C. Anal. Calcd for C20H25BrN2S·1/4CH2Cl2: C,
57.01; H, 6.02; N, 6.57. Found: C, 57.03; H, 5.95; N, 6.82. MS (ESI):
m/z 325 [M − Br]+.
H), 7.51−7.27 (m, 12 H, Ar-H) 7.30 (s, 1 H, NCHPh2), 4.95 (t, 3JH−H
3
= 7 Hz, 2 H, NCH2), 3.58 (t, JH−H = 6 Hz, 2 H, CH2Br), 2.77−2.65
(m, 2 H, CH2). 13C{1H} NMR (75 MHz, CDCl3): δ 143.6 (NCHN),
135.9, 135.7, 132.6, 130.2, 130.1, 129.1, 128.1, 127.9, 115.7, 114.0 (Ar-
C), 67.6 (NCHPh2), 47.0 (NCH2), 32.6 (CH2Br), 30.5 (CH2). Mp:
206 °C. Anal. Calcd for C23H22Br2N2: C, 56.81; H, 4.56; N, 5.76.
Found: C, 56.44; H, 4.33; N, 5.58. MS (ESI): m/z 405 [M − Br]+.
1-Benzyl-3-(2-(isopropylthio)ethyl)benzimidazolium Bro-
mide (4a). 2-Mercaptopropane (351 μL, 3.78 mmol, 1.50 equiv)
was dissolved in degassed acetonitrile (30 mL). Sodium hydroxide
(151 mg, 3.78 mmol, 1.50 equiv) in water (1 mL) was added, and the
resulting mixture was stirred for 30 min at ambient temperature. Then,
2a (1.00 g, 2.52 mmol, 1.00 equiv) was added, and stirring was
continued for 15 h at ambient temperature. After this time, the
volatiles were removed under reduced pressure. The solid residue was
suspended in dichloromethane (10 mL) and filtered. The solvent was
removed under reduced pressure, and the residue was washed with
diethyl ether (5 mL). A white solid was obtained (978 mg, 2.50 mmol,
99%). 1H NMR (300 MHz, CDCl3): δ 11.60 (s, 1 H, NCHN), 7.69−
7.74 (m, 1 H, Ar-H), 7.46−7.65 (m, 6 H, Ar-H), 7.36−7.40 (m, 2 H,
1-Isobutyl-3-(3-(isopropylthio)propyl)benzimidazolium Bro-
mide (5b). 5b was prepared in analogy to 4a from 2-
mercaptopropane (849 μL, 9.20 mmol, 1.50 equiv), sodium hydroxide
(369 mg, 9.20 mmol, 1.50 equiv), and 3b (2.31 g, 6.10 mmol, 1.00
equiv). A brown oil was obtained (1.76 g, 4.74 mmol, 78%). 1H NMR
(300 MHz, CDCl3): δ 11.49 (s, 1 H, NCHN), 7.84−7.78 (m, 1 H, Ar-
3
H), 7.72−7.60 (m, 3 H, Ar-H), 4.80 (t, JH−H = 7 Hz, 2 H, NCH2),
3
3
4.41 (d, JH−H = 8 Hz, 2 H, NCH2), 2.89 (sept, JH−H = 7 Hz, 1 H,
3
SCH), 2.66 (t, JH−H = 7 Hz, 2 H, SCH2), 2.43−2.30 (m, 3 H, CH,
CH2), 1.21 (d, 3JH−H = 7 Hz, 6 H, CH3), 1.02 (d, JH−H = 7 Hz, 6 H,
3
CH3). 13C{1H} NMR (75 MHz, CDCl3): δ 143.9 (NCHN), 132.1,
132.0, 127.8, 113.8 (Ar-C), 55.0 (NCH2), 46.8 (NCH2), 36.0 (SCH);
29.9 (CH), 29.6 (SCH2), 27.8 (CH2), 24.0 (CH3), 20.5 (CH3). No
correct elemental analysis could be obtained for this compound,
despite several attempts. MS (ESI): m/z 291 [M − Br]+.
1-Benzhydryl-3-(3-(isopropylthio)propyl)benzimidazolium
Bromide (5c). 5c was prepared in analogy to 4a from 2-
mercaptopropane (1.48 mL, 16.1 mmol, 1.50 equiv), sodium
hydroxide (644 mg, 16.1 mmol, 1.50 equiv), and 3c (5.21 g, 10.7
mmol, 1.00 equiv). A white solid was obtained (3.09 g, 6.42 mmol,
3
Ar-H), 5.84 (s, 2 H, NCH2Ph), 4.87 (t, JH−H = 7 Hz, 2 H, NCH2),
3
3
3.19 (t, JH−H = 7 Hz, 2 H, SCH2), 3.17 (sept, JH−H = 7 Hz, 1 H,
SCH), 1.26 (d, JH−H = 7 Hz, 6 H, CH3). 13C{1H} NMR (75 MHz,
3
CDCl3): δ 144.0 (NCHN), 133.3, 132.1, 131.7, 130.0, 129.9, 128.9,
127.8, 114.4, 113.8 (Ar-C), 52.1 (NCH2Ph), 47.8 (NCH2), 35.9
(SCH), 30.5 (SCH2), 24.0 (CH3). Mp: 165 °C. Anal. Calcd for
C19H23BrN2S·H2O: C, 55.74; H, 6.16; N, 6.84. Found: C, 56.11; H,
5.80; N, 6.88. MS (ESI): m/z 311 [M − Br]+.
1
60%). H NMR (300 MHz, CDCl3): δ 10.88 (s, 1 H, NCHN), 7.82
(d, 3JH−H = 8 Hz, 1 H, Ar-H), 7.58 (dt, 4JH−H = 1 Hz, 3JH−H = 7 Hz, 1
H, Ar-H), 7.47−7.33 (m, 12 H, Ar-H), 7.29 (s, 1 H, NCHPh2), 4.87
3
3
(t, JH−H = 7 Hz, 2 H, NCH2), 2.85 (sept, JH−H = 7 Hz, 1 H, SCH),
3
3
2.65 (t, JH−H = 7 Hz, 2 H, SCH2), 2.34 (quint, JH−H = 7 Hz, 2 H,
1-Isobutyl-3-(2-(isopropylthio)ethyl)benzimidazolium Bro-
mide (4b). 4b was prepared in analogy to 4a from 2-
mercaptopropane (628 μL, 6.80 mmol, 1.51 equiv), sodium hydroxide
(272 mg, 6.80 mmol, 1.51 equiv), and 2b (1.63 g, 4.50 mmol, 1.00
CH2), 1.18 (d, JH−H = 7 Hz, 6 H, CH3). 13C{1H} NMR (75 MHz,
3
CDCl3): δ 143.8 (NCHN), 135.8, 132.6, 131.7, 130.1, 129.2, 127.8,
127.7, 115.7, 114.0 (Ar-C), 67.4 (NCHPh2), 47.3 (NCH2), 36.0
(SCH), 29.6 (SCH2), 27.9 (CH2), 24.0 (CH3). Mp: 200 °C. Anal.
Calcd for C26H29BrN2S: C, 64.86; H, 6.07; N, 5.84. Found: C, 64.80;
H, 5.73; N, 5.88. MS (ESI): m/z 401 [M − Br]+.
cis-Dibromido(1-benzyl-3-(2-(isopropylthio)ethyl)-
benzimidazolin-2-ylidene-κ2C,S)platinum(II) (6a). 4a (117 mg,
0.30 mmol, 1.00 equiv) and silver(I) oxide (35 mg, 0.15 mmol, 0.50
equiv) were suspended in dichloromethane (15 mL) and stirred at
ambient temperature for 15 h shielded from light. Platinum(II)
bromide (106 mg, 0.30 mmol, 1.00 equiv) was dissolved in DMSO (5
mL) by stirring for 10 min at 80 °C. After the [PtBr2(dmso)2] solution
had cooled to ambient temperature, the silver complex solution was
added by filtration over a short plug of Celite, and the resulting
mixture was stirred for 1 h at ambient temperature. Then the solution
was filtered over Celite. The solution was extracted with water (2 × 50
1
equiv). A white solid was obtained (1.26 g, 3.53 mmol, 78%). H
NMR (300 MHz, CDCl3): δ 11.33 (s, 1 H, NCHN), 7.79−7.59 (m, 4
H, Ar-H), 4.91 (t, 3JH−H = 7 Hz, 2 H, NCH2), 4.40 (d, 3JH−H = 7 Hz, 2
3
3
H, NCH2), 3.19 (sept, JH−H = 7 Hz, 1 H, SCH), 3.17 (t, JH−H = 7
3
Hz, 2 H, SCH23), 2.41 (m, 1 H, CH), 1.24 (d, JH−H = 7 Hz, 6 H,
CH3), 1.05 (d, JH−H = 7 Hz, 6 H, CH3). 13C{1H} NMR (75 MHz,
CDCl3): δ 144.3 (NCHN), 132.1, 131.9, 127.8, 113.8 (Ar-C), 55.1
(NCH2), 47.6 (NCH2), 35.7 (SCH), 30.6 (CH), 29.6 (SCH2), 24.0
(CH3), 20.5 (CH3). Mp: 122 °C. Anal. Calcd for C16H25BrN2S·1/
5CH2Cl2: C, 51.98; H, 6.84; N, 7.48. Found: C, 52.37; H, 6.68; N,
7.67. MS (ESI): m/z 277 [M − Br]+.
1-Benzhydryl-3-(2-(isopropylthio)ethyl)benzimidazolium
Bromide (4c). 4c was prepared in analogy to 4a from 2-
mercaptopropane (903 μL, 9.78 mmol, 1.50 equiv), sodium hydroxide
177
dx.doi.org/10.1021/om400929t | Organometallics 2014, 33, 172−180